Cite
MLA Citation
Ekaterina Gibiansky et al.. “Pharmacokinetics, exposure, efficacy and safety of obinutuzumab in rituximab‐refractory follicular lymphoma patients in the GADOLIN phase III study.” British journal of clinical pharmacology, vol. 85, no. 9, 2019, pp. 1935–1945. http://access.bl.uk/ark:/81055/vdc_100089697604.0x000018